Abstract
The Escherichia coli heal-labile enterotoxin (LT) is a potent inducer of mucosal immune responses. In a previous study (L. DeHaan, W. R. Verweij, M. Holtrop, E. Agsteribbe, and J. Wilschut, Vaccine 14:620-626, 1996), we have shown that efficient induction of an LTB-specific mucosal immune response by LT requires the presence of the LTA chain, suggesting a possible role of the enzymatic activity of LTA in the induction of these responses. In the present study, we generated LT mutants with altered ADP-ribosylation activities and evaluated their immunogenicity upon intranasal administration to mice. The results demonstrate that the mucosal immunogenicity of LT is not dependent on its ADP-ribosylation activity.
Cite
CITATION STYLE
De Haan, L., Verweij, W. R., Feil, I. K., Lijnema, T. H., Hol, W. G. J., Agsteribbe, E., & Wilschut, J. (1996). Mutants of the Escherichia coli heat-labile enterotoxin with reduced ADP-ribosylation activity or no activity retain the immunogenic properties of the native holotoxin. Infection and Immunity, 64(12), 5413–5416. https://doi.org/10.1128/iai.64.12.5413-5416.1996
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.